Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents
- 20 June 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (14) , 6765-6784
Abstract
Benzoxaboroles, as a novel class of bioactive molecules with unique physicochemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug. Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking so far. In this study, we report the design, synthesis, and anticancer structure-activity relationship of a series of 7-propanamide benzoxaboroles. Compounds 103 and 115 showed potent activity against ovarian cancer cells with IC50 values of 33 and 21 nM. Apoptosis was induced by these compounds and colony formation was effectively inhibited. Furthermore, they also showed excellent efficacy in ovarian tumor xenograft mouse model.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2017YFA0505200)
- National Natural Science Foundation of China (81222042, 81573264)
- E-Institutes of Shanghai Universities (EISU) Chemical Biology Division
This publication has 28 references indexed in Scilit:
- Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetaseScientific Reports, 2013
- Chalcone–Benzoxaborole Hybrid Molecules as Potent Antitrypanosomal AgentsJournal of Medicinal Chemistry, 2012
- Synthesis of novel benzoxaborole-containing phenylalanine analoguesTetrahedron Letters, 2011
- Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesBioorganic & Medicinal Chemistry Letters, 2011
- Convenient and versatile synthesis of formyl-substituted benzoxaborolesTetrahedron, 2009
- Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitisBioorganic & Medicinal Chemistry Letters, 2009
- An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing SiteScience, 2007
- Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the Potential Treatment of OnychomycosisJournal of Medicinal Chemistry, 2006
- Approval Summary for Bortezomib for Injection in the Treatment of Multiple MyelomaClinical Cancer Research, 2004
- Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1Journal of the American Chemical Society, 1958